person

Gennaro C.

Country
Italy
Department
Oncological Gynecology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 61 partner sites.

Specializations

Gynecologic Oncology

Investigator focuses on malignant conditions of the female reproductive system, including ovarian, fallopian tube, primary peritoneal, and endometrial cancers.

  • Advanced Epithelial Ovarian Cancer
  • High-Risk HER2-Positive Endometrial Cancer
  • Recurrent Metastatic Endometrial Carcinoma
  • Fallopian Tube Carcinoma

Clinical activity includes both adjuvant and metastatic settings.

Hematologic Malignancies

Research emphasis on blood‑borne neoplasms such as acute myeloid leukemia with FLT3 mutation, myelodysplastic syndromes, chronic lymphocytic leukemia, and myeloproliferative neoplasms.

  • FLT3‑mutated Acute Myeloid Leukemia
  • Myelodysplastic Syndromes with del5q
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Primary Myelofibrosis

Targets include molecular drivers and disease‑modifying pathways.

Thoracic Oncology

Investigator engages in trials for malignant lung diseases, spanning non‑small cell and small‑cell histologies with actionable alterations.

  • ALK‑positive Non‑Small Cell Lung Cancer
  • EGFR‑mutated NSCLC
  • KRAS G12C‑mutated NSCLC
  • Extensive‑Stage Small‑Cell Lung Cancer

Work includes both targeted agents and immunotherapy combinations.

Melanoma and Cutaneous Oncology

Focus on malignant melanocytic and neuroendocrine skin tumors, covering cutaneous, mucosal, uveal, and Merkel cell carcinoma.

  • Advanced Cutaneous Melanoma
  • Mucosal Melanoma
  • Uveal Melanoma
  • Merkel Cell Carcinoma

Investigations address adjuvant, neoadjuvant, and metastatic treatment strategies.

Urothelial and Bladder Cancer

Investigator studies bladder malignancies ranging from non‑muscle‑invasive to muscle‑invasive and metastatic urothelial carcinoma.

  • Muscle‑Invasive Bladder Cancer
  • Non‑Muscle‑Invasive Bladder Cancer
  • Urothelial Carcinoma with HER2 overexpression
  • Metastatic Urothelial Cancer

Emphasis on immunotherapy and antibody‑drug conjugates.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.